Inventor
SOREQ HERMONA
IL24 patents
⚠️ This page may combine multiple inventors who share the name “SOREQ HERMONA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
17 patentsUS5891725AApr 6, 1999
Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
YISSUM RES DEV CO141 citations98
US7456154B2Nov 25, 2008
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
YISSUM RES DEV CO121 citations93
US6025183AFeb 15, 2000
Transgenic animal assay system for anti-cholinesterase substances
YISSUM RES DEV CO22 citations91
US5932780AAug 3, 1999
Transgenic non-human animal assay system for anti-cholinesterase substances
YISSUM RES DEV CO33 citations91
US7074915B2Jul 11, 2006
Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
YISSUM RES DEV CO19 citations86
US6987211B1Jan 17, 2006
Transgenic non-human mammals producing a cholinesterase in their milk
YISSUM RES DEV CO12 citations82
US5595903AJan 21, 1997
Genetically engineered human acetylcholinesterase
YISSUM RES DEV CO17 citations75
US5807671ASep 15, 1998
Method of screening for genetic predisposition to anticholinesterase therapy
YISSUM RES DEV CO15 citations72
US6110742AAug 29, 2000
Synthetic antisense oligodeoxynucleotides targeted to AChE
YISSUM RES DEV CO12 citations71
US6258780B1Jul 10, 2001
Method and composition for enabling passage through the blood-brain-barrier
YISSUM RES DEV CO8 citations68
US6475998B1Nov 5, 2002
Methods and compositions for the treatment of injury to the central nervous system
YISSUM RES DEV CO5 citations60
US6121046ASep 19, 2000
Synthetic antisense oligodeoxynucleotides targeted to human ache
YISSUM RES DEV CO4 citations60
US7494783B2Feb 24, 2009
Method for assessing trait anxiety by determining cholinergic status
YISSUM RES DEV CO2 citations53
US7067486B2Jun 27, 2006
Acetylcholinesterase-derived peptides and uses thereof
YISSUM RES DEV CO2 citations51
US7063948B1Jun 20, 2006
Uses of antibodies against AChE and peptides thereof
YISSUM RES DEV CO1 citations49
US8722876B2May 13, 2014
Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders
YISSUM RES DEV CO1 citations48
US7838493B2Nov 23, 2010
Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof
YISSUM RES DEV CO0 citations42
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD
3 patentsUS11193034B2Dec 7, 2021
Hybrid nanoparticles as photoinitiators
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations55
US10174320B2Jan 8, 2019
Downregulating miR-132 for the treatment of lipid related disorders
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD1 citations50
US10442944B2Oct 15, 2019
Hybrid nanoparticles as photoinitiators
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD0 citations45